Biotechnology
SunRock Biopharma. Therapeutic antibodies
SunRock Biopharma
Project Description
SunRock Biopharma is looking for companies that bet on financing projects focused on the development of therapeutic antibodies to fight cancer, following the line of development of antiCCR9 and anti-HER3 therapeutic antibodies.
Description of the Area of Activity / Technology
Development of therapeutic antibodies directed against Chemokine Receptor 9, CCR9, a new therapeutic target in which its overexpression is correlated with the invasive capacity of Acute T Lymphoblastic Leukemia, Chronic T Lymphoblastic Leukemia and solid tumors such as ovarian cancer, prostate cancer, breast cancer and melanoma.
Others
Projects
Join us!
Do you want to appear on the platform? If you are part of the biotechnological sector of the Euroregion Galicia – North of Portugal, sign up!